SeaSpine Holdings (SPNE) Reports Q4 Loss, Misses Revenue Estimates
SeaSpine Holdings (SPNE) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to loss of $0.45 per share a year ago. These more...
Agile Therapeutics (AGRX) Reports Q4 Loss, Misses Revenue Estimates
Agile Therapeutics (AGRX) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to loss of $0.10 per share a year ago. These more...
TransEnterix (TRXC) Flat As Market Gains: What You Should Know
In the latest trading session, TransEnterix (TRXC) closed at $3.72, marking no change from the previous day. This change lagged the S&P 500’s daily gain of 2.38%. Meanwhile, the Dow gained 1.95%, and the Nasdaq, more...
Bionano Genomics, Inc. (BNGO) Gains But Lags Market: What You Should Know
Bionano Genomics, Inc. (BNGO) closed at $9.84 in the latest trading session, marking a +1.13% move from the prior day. The stock lagged the S&P 500’s daily gain of 2.38%. Meanwhile, the Dow gained 1.95%, more...
Conformis, Inc. Announces Clearance in Australia for iTotal® PS, the Only Personalized, Posterior-Stabilized Total Knee Replacement System
The iTotal® PS total knee replacement system is designed so that its patient-specific implants fit the unique size and shape of each patient’s knee, and provide optimal stability throughout the full range of motion BILLERICA, more...
SHAREHOLDER ALERT: WeissLaw LLP Reminds IPHI, OBLN, IACA, and TPGY Shareholders About Its Ongoing Investigations
SHAREHOLDER ALERT: WeissLaw LLP Reminds IPHI, OBLN, IACA, and TPGY Shareholders About Its Ongoing Investigations PR Newswire NEW YORK , March 1, 2021 /PRNewswire/ — If you own shares in any of the companies listed more...
Agile Therapeutics Reports Fourth Quarter & Full Year 2020 Financial Results; Expands Loan Facility With Perceptive Advisors
Perceptive Advisors Increases Credit Facility to $45 million, with $25 million potentially available Achieved Gross Revenue Target In Fourth Quarter 2020, Reflecting Initial Stocking of Twirla® (levonorgestrel and ethinyl estradiol) transdermal system Announces Agreement with more...
SeaSpine Announces Fourth Quarter and Full-Year 2020 Results
Reports Record Quarterly Revenue, Driven by U.S. Sales Channel CARLSBAD, Calif., March 01, 2021 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of more...
Motus GI to Participate in Two Upcoming Investor Conferences in March 2021
FORT LAUDERDALE, Fla., March 01, 2021 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency more...
Assertio Holdings, Inc. to Present at Virtual Roth Conference on Monday, March 15, 2021
LAKE FOREST, Ill., March 01, 2021 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that Dan Peisert, President and Chief Executive Officer of Assertio, will present at and participate more...